Asami H, Ito Y, Aida J S, Okada Y, Takagi K, Koike N, Sakamoto A, Yokose T
Department of Clinical Pathology, Tokyo Metropolitan Tama Geriatric Hospital, Higashimurayama, Japan.
Pathol Int. 1997 Dec;47(12):876-82. doi: 10.1111/j.1440-1827.1997.tb03721.x.
Presented is a case report of a urinary bladder carcinoma that had an unusual morphology and phenotype. A 65-year-old Japanese man complained of gross hematuria. Cytological examination of the urine before a partial cystectomy revealed small, round atypical cells with a high nuclear/cytoplasmic ratio, scant cytoplasm, and hyperchromatic nuclei with coarse and granular chromatin in a bloody background. Several tumor cells had relatively large and vesicular nuclei with prominent eosinophilic nucleoli and obscure perinucleolar halos. A small number of large atypical urothelial cells were also recognized. The tumor recurred locally 3 months after the operation. The urine cytology during recurrence showed the same features without the atypical urothelial cells. These cytological findings suggested a case of small cell undifferentiated carcinoma (SCUC) combined with transitional cell carcinoma (TCC). An histology of the resected specimen before the recurrence revealed that the SCUC was consistent with a variant type of SCUC proposed for the lung and showed transition with TCC in situ. M-VAC chemotherapy after a total cystectomy was less effective. The patient died 6 months after diagnosis. A variant subtype of SCUC of the urinary bladder associated with TCC in situ has not been previously reported. Although this histological type is very rare, its earlier cytological detection is needed for appropriate therapy.
本文报告了一例具有不寻常形态和表型的膀胱癌病例。一名65岁的日本男性主诉肉眼血尿。在部分膀胱切除术前对尿液进行的细胞学检查显示,在血性背景中存在小的圆形非典型细胞,核质比高,胞质稀少,核深染,染色质粗糙且呈颗粒状。几个肿瘤细胞具有相对较大的泡状核,嗜酸性核仁突出,核仁周围晕模糊。还识别出少数大的非典型尿路上皮细胞。术后3个月肿瘤局部复发。复发期间的尿液细胞学检查显示相同特征,但无典型尿路上皮细胞。这些细胞学发现提示为小细胞未分化癌(SCUC)合并移行细胞癌(TCC)。复发前切除标本的组织学检查显示,SCUC与为肺提出的一种SCUC变异型一致,并显示与原位TCC有过渡。全膀胱切除术后的M-VAC化疗效果较差。患者在诊断后6个月死亡。膀胱SCUC与原位TCC相关的变异亚型此前尚未见报道。尽管这种组织学类型非常罕见,但为了进行适当的治疗,需要更早地进行细胞学检测。